Dr Rohla is currently completing his specialist training in cardiology at the 3rd Medical Department for Cardiology and Intensive Care Medicine, Klinik Ottakring (formerly Wilhelminenhospital) in Vienna, Austria. His research is focused around the medical and invasive treatment of acute coronary syndromes, antithrombotic therapies in patients with coronary artery disease or atrial fibrillation, and control of risk factors such as hypertension or hyperlipidaemia. Main clinical areas of interest are interventional cardiology and intensive care medicine.  

Dr Miklos Rohla has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Sanofi Aventis.